Related Experiment Video
Updated: May 12, 2026

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury
Published on: December 17, 2014
Pluripotent possibilities: human umbilical cord blood cell treatment after neonatal brain injury
Tatyana Verina1, Ali Fatemi, Michael V Johnston
1Neurology and Developmental Medicine, Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, Maryland 21205, USA.
Insights
Umbilical cord blood stem cells show promise for treating brain injuries in newborns. These cells offer neuroregeneration potential, targeting multiple injury aspects for improved outcomes in developing brains.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Neonatal Neurology
Background:
- Perinatal hypoxic-ischemic brain injury and stroke are significant causes of long-term neurological disability in developing brains.
- Emerging research indicates that stem cell transplantation, specifically from human umbilical cord blood, may offer therapeutic benefits.
Purpose of the Study:
- To explore the therapeutic potential of umbilical cord blood stem cells for neuroregeneration and functional recovery following perinatal brain injury.
- To investigate the capacity of these stem cells to target multiple neuropathologic events and their suitability for transplantation.
Main Methods:
- Review of preclinical studies on stem cell transplantation in various brain injury models, with a focus on immature animal models.
- Analysis of factors influencing transplanted cell survival, migration, and function, including recipient age and sex.
Main Results:
- Human umbilical cord blood stem cells possess pluripotent capacity, enabling simultaneous targeting of multiple injury pathways.
- Transplanted cell survival, migration, and function are influenced by recipient biological characteristics.
- Preclinical data support ongoing clinical safety trials in neonates.
Conclusions:
- Umbilical cord blood stem cells present a promising therapeutic option for perinatal brain injuries due to their regenerative potential and immunologic properties.
- Further research is essential to optimize transplantation protocols and fully elucidate the mechanisms underlying their efficacy.
- Findings from preclinical studies are guiding current clinical investigations in neonates.
Abstract:
Perinatal hypoxic-ischemic brain injury and stroke in the developing brain remain important causes of chronic neurologic morbidity. Emerging data suggest that transplantation of umbilical cord blood-derived stem cells may have therapeutic potential for neuroregeneration and improved functional outcome. The pluripotent capacity of stem cells from the human umbilical cord blood provides simultaneous targeting of multiple neuropathologic events initiated by a hypoxic-ischemic insult. Their high regenerative potential and naïve immunologic phenotype makes them a preferable choice for transplantation. A multiplicity of transplantation protocols have been studied with a variety of brain injury models; however, only a few have been conducted on immature animals. Biological recipient characteristics, such as age and sex, appear to differentially modulate responses of the animals to the transplanted cord blood stem cells. Survival, migration, and function of the transplanted cells have also been studied and reveal insights into the mechanisms of cord blood stem cell effects. Data from preclinical studies have informed current clinical safety trials of human cord blood in neonates, and further work is needed to continue progress in this field.
Related Concept Videos
iPS Cell Differentiation
Stem Cell Culture
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
Embryonic Stem Cells

